AMGN BUE Week ended 24 Jul 2026

Weekly Investor Report

Name: AMGN weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Amgen Inc. · Healthcare · Drug Manufacturers - General

Open interactive chart View report data Download investor PDF

Latest close 20,020 ARS

4.3% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 13.3% above the Trend Line and sits at 95.9% of its 52-week range. The latest completed week returned 4.3%, after a 8.7% four-week move. The latest news-sentiment score is 51/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.

Setup score 66 out of 100

Latest Close 20,020 ARS 24 Jul 2026

1W Return 4.3% latest completed week

4W Return 8.7% short-term follow-through

12W Return 15.7% quarterly tape

Trend Breadth 84.6% 44 of 52 weeks active

Volume Ratio 0.5x vs 13-week average

What is working

The trend backdrop is active with a 4-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.

What could go wrong

No major top-level risk cluster is currently dominant.

What to watch next

Price is close to its 52-week high; watch for continuation or exhaustion.
Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 4.3% Latest completed week; four-week move 8.7%. Indicator stack 60/98 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.35% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 25 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 13.3% above the Trend Line and sits at 95.9% of its 52-week range. The latest completed week returned 4.3%, after a 8.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

12,320 ARS 95.9% 20,350 ARS

Range location95.9%Shows where the latest close sits between the 52-week low and high.

Trend distance13.3%Price premium or discount versus the weekly Trend Line.

Fair-value gap29.4%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-1.6%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7112-week average 0.55

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.71Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 8.7% over four weeks, 15.7% over 12 weeks, and 52.2% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W4.3%

4W8.7%

12W15.7%

26W15.7%

52W52.2%

Active trend streak4 weeks

Active weeks in one year44

Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.86Latest activity-pressure read.

Pressure change408.0%Four-week change in activity pressure.

Leadership-0.89Latest relative-leadership reading.

RS change79.1%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment51/100

Weighted news tone is neutral across 25 relevant articles.

4 positive · 20 neutral · 1 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-1.6%Distance below the 52-week high.

13-week volatility4.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

30 Jan 27 Feb 27 Mar 24 Apr 22 May 19 Jun 24 Jul

Weeks higher13 of 2613 weeks finished lower.

Best week+10.7%Week of 6 Feb.

Worst week-5.9%Week of 20 Mar.

Latest week+4.3%Week of 24 Jul.

Shape of recent returns

Strong gains7

Modest gains6

Flat weeks0

Modest losses7

Sharp losses6

Recent vol4.5%13-week weekly-return volatility.

Base vol4.7%52-week weekly-return volatility.

Up/down split28/24Count of positive and negative weeks in the 52-week window.

Average skew4.2% / -2.9%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorAR Healthcare

4-week rank4 / 20

Group average4.0%

Trend breadth45.0%

Trend45.0%active weekly trend signals

MD80.0%positive activity pressure

RS35.0%positive relative leadership

Four-week leaders

TMO · BUE15.1%ABT · BUE14.7%BMY · BUE13.3%AMGN · BUE8.7%ABBV · BUE7.3%

IndustryAR Drug Manufacturers - General

4-week rank2 / 13

Group average3.8%

Trend breadth61.5%

Trend61.5%active weekly trend signals

MD76.9%positive activity pressure

RS46.2%positive relative leadership

Four-week leaders

BMY · BUE13.3%AMGN · BUE8.7%ABBV · BUE7.3%JNJ · BUE7.2%MRK · BUE5.7%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

Indicator analysis38/100

Latest 12-week confirmation: trend 4/12, activity pressure 4/12, relative leadership 1/12.

Activity pressure 0.71; No reversal markers Next-Week ExpectancyPositive 55.35%

Next-week expectancy is positive with a 55.35% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 25 relevant articles.

Amgen (AMGN) Stock Could Be A Bargain On Cash Flow But Fairly Priced On Earnings Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
24 Jul 2026	20,020 ARS	4.3%	17,668 ARS	15,476 ARS	0.86	-0.89	4.2K	On
17 Jul 2026	19,200 ARS	1.7%	17,560 ARS	15,430 ARS	0.88	-2.39	11.2K	On
10 Jul 2026	18,880 ARS	-5.2%	17,487 ARS	15,388 ARS	0.45	-6.41	915	On
3 Jul 2026	19,910 ARS	8.1%	17,390 ARS	15,346 ARS	0.21	1.11	11.8K	On
26 Jun 2026	18,410 ARS	8.5%	17,284 ARS	15,291 ARS	-0.28	-4.24	35.4K	Off
19 Jun 2026	16,970 ARS	-4.4%	17,247 ARS	15,246 ARS	-0.83	-16.11	1.2K	Off
12 Jun 2026	17,750 ARS	0.6%	17,250 ARS	15,212 ARS	-0.79	-13.91	547	Off
5 Jun 2026	17,640 ARS	5.9%	17,218 ARS	15,173 ARS	-0.99	-7.06	4.2K	Off
29 May 2026	16,660 ARS	-0.8%	17,153 ARS	15,130 ARS	-1.07	-14.40	2.1K	Off
22 May 2026	16,800 ARS	4.0%	17,095 ARS	15,093 ARS	-1.04	-3.91	30.2K	Off
15 May 2026	16,150 ARS	-1.8%	17,042 ARS	15,055 ARS	-1.00	-2.47	4.9K	Off
8 May 2026	16,440 ARS	-5.0%	17,016 ARS	15,022 ARS	-0.93	-2.50	8.4K	Off
1 May 2026	17,310 ARS	0.3%	16,949 ARS	14,987 ARS	-0.91	0.70	3.9K	On
24 Apr 2026	17,260 ARS	-0.2%	16,878 ARS	14,945 ARS	-0.89	0.31	18.2K	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.